NCT04265612

Brief Summary

The objective of the study is to measure the efficacy of the use of single-use portable negative pressure therapy (PICO ®) in the prevention of surgical wound infections (SSI) from cardiac surgery under extracorporeal circulation compared to single-use hydrocolloid dressings "Aquacel Surgical".

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
253

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 5, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

November 5, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 11, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 13, 2021

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2022

Completed
Last Updated

July 21, 2023

Status Verified

February 1, 2021

Enrollment Period

1.7 years

First QC Date

November 5, 2019

Last Update Submit

July 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of infection of the sternal surgical wound.

    The state of the surgical wound will be assessed and recorded on the wound care data collection sheet. Note whether the wound looks good or not and whether there are any complications: exudate, appearance of the wound, necrosis of the wound edges, redness, maceration of the wound or wound dehiscence.

    1-3 months

Study Arms (2)

Negative Pressure dressing

EXPERIMENTAL

Pico®" negative pressure dressing that will be placed in the operating room in both sternal wound and saphenectomy. This dressing will remain in place for 7 days without getting up, unless it has become saturated, in which case, only the dressing will be changed.

Procedure: Pico®" negative pressure dressing

Aquacel hydrogel dressing

ACTIVE COMPARATOR

Aquacel Surgical®" hydrogel dressing that will be placed in the operating room in both sternal wound and saphenectomy. This dressing will remain in place for 7 days without getting up, unless it has become saturated, in which case, only the dressing will be changed.

Procedure: Aquacel Surgical®" hydrogel dressing

Interventions

Pico®" negative pressure dressing that will be placed in the operating room in both sternal wound and saphenectomy.The dressing will remain on for 7 days without waking up, unless it is saturated, in which case only the dressing will be changed

Negative Pressure dressing

Aquacel Surgical®" hydrogel dressing that will be placed in the operating room in both sternal wound and saphenectomy. This dressing will remain in place for 7 days without getting up, unless it has become saturated, in which case, only the dressing will be changed.

Aquacel hydrogel dressing

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing elective or emergency cardiac surgery with extracorporeal circulation heart surgery who will have a median sternotomy.
  • Who signs Informed Consent after agreeing to participate in the microbiological study.

You may not qualify if:

  • Patients undergoing emergency cardiac surgery that does not time to randomization and/or coding.
  • Patients with immunocompromised haematological diseases.
  • Patients who are allergic or present some hypersensitivity to the dressing or excipient.
  • Patients who are participating in another experimental study.
  • Patients who, due to their fragility or comorbidity, the surgeon considers that they should not undergo randomization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pilar Garrido Martín

Santa Cruz de Tenerife, 38320, Spain

Location

MeSH Terms

Conditions

Surgical Wound Infection

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Rafael Martínez Sanz, PhD

    Hospital Universitario de Canarias

    STUDY DIRECTOR
  • Pilar Garrido Martín, PhD

    Hospital Universitario de Canarias

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
External evaluator: care provider
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 5, 2019

First Posted

February 11, 2020

Study Start

November 5, 2019

Primary Completion

July 13, 2021

Study Completion

May 18, 2022

Last Updated

July 21, 2023

Record last verified: 2021-02

Locations